New eye scanner could replace dye injections for retinal disease
NCT ID NCT03279939
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tested a new imaging device called OCT angiography (OCTA) that takes 3D pictures of blood vessels in the back of the eye without needing dye injections. Researchers compared OCTA images to standard dye-based imaging in 88 people with retinal blood vessel problems or normal eyes. The goal was to see if OCTA provides good image quality and shows clinically useful details.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this imaging method could replace dye-based tests, making eye exams faster and safer for patients with retinal conditions.
- What could go wrong
- This is a small, completed study focused on image quality, not treatment. The device may not be better than existing methods for all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BRANCH RETINAL VEIN OCCLUSION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Retina Consultants of Houston
Houston, Texas, 77030, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could eye drops replace injections for a leading cause of blindness?
- AI eye doctor: could software catch diabetic blindness sooner?
- Can eye scans reveal hidden clues about diabetes damage?
- Eye injection aims to tame leading causes of blindness
- AI could predict which eye treatments work best for Diabetes-Related vision loss
- New eye drug aims to restore vision in Diabetes-Related swelling